Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

MERYEM TEMİZ REŞİTOĞLU

Doktor Öğretim Üyesi

Mersin Üniversitesi Eczacılık Fakültesi Eczacılık Meslek Bilimleri Bölümü

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmakoloji
Articles 30 YÖKSİS 30 · OpenAlex 0 Total citations 444 h-index 13 · OpenAlex OpenAlex coverage %83 matched 25 / 30 Q1 articles 0 Scopus · WoS Q1 1 Best field rank #47 / 169 Side field · top 27.8% Co-authors 41 3 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 25 + YÖKSİS · co-author record: 7
h-index 13 Percentile in Türkiye: 84 #184 of 1,208 at their university by h-index
i10-index
14
Total citations
444
Top 16% in Türkiye
Per article
13.9
FWCI
1.93
1.00 = world average
World top 1%
1
World top 10%
3

Most cited articles

  1. Activation of mTOR/IκB-α/NF-κB pathway contributes to LPS-induced hypotension and inflammation in rats 2017 world top 10% 74 citations
  2. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms 2017 world top 10% 65 citations
  3. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway 2018 31 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 7 articles (83 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 1.

Citing publications Crossref 109 publications citing 25 DOI-bearing articles · 9 Türkiye-affiliated
  • 2018 3
  • 2019 27
  • 2020 30
  • 2021 26
  • 2022 12
  • 2025 8
  • 2026 3
  1. DOI 10.1016/b978-0-443-29289-7.00011-4 2026
  2. DOI 10.1016/j.fsi.2025.111016 2026
  3. DOI 10.1016/j.phymed.2025.157634 2026
  4. DOI 10.4103/regenmed.regenmed-d-25-00039 2025
  5. DOI 10.56782/pps.520 2025
  6. DOI 10.1007/s12035-025-05389-0 2025
  7. DOI 10.1080/17435889.2025.2587713 2025
  8. DOI 10.3389/fmicb.2025.1710051 2025
  9. DOI 10.1186/s41065-025-00598-y 2025
  10. DOI 10.1371/journal.pone.0335250 2025
  11. DOI 10.1016/j.celrep.2025.116568 2025
  12. Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt–Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats TR Meryem Temiz-Resitoglu et al. · Journal of Cardiovascular Pharmacology · 2022
  13. Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MEK1/ERK1/2 activity TR Çağla AKINCI UYSAL et al. · Cukurova Medical Journal · 2022 · cites 3 articles of this academic
  14. DOI 10.1016/j.jgr.2021.12.008 2022
  15. DOI 10.1016/j.bbrc.2021.12.047 2022
  16. DOI 10.1016/j.freeradbiomed.2022.01.004 2022
  17. DOI 10.3389/fimmu.2022.818518 2022
  18. DOI 10.1016/j.biopha.2021.112430 2022
  19. DOI 10.1080/13543784.2022.2040014 2022 · cites 2 articles of this academic
  20. DOI 10.1186/s13567-022-01024-1 2022
  21. DOI 10.1007/s11481-021-10037-0 2022
  22. DOI 10.1016/j.phymed.2022.154025 2022
  23. DOI 10.1016/j.jep.2021.114740 2022
  24. Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model TR Sefika Pinar Senol et al. · Neurochemical Research · 2021 · cites 3 articles of this academic
  25. Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protectıve Agent on Rat Synaptosomes Treated with Aβ(1-42) TR Ceyhan Hacioglu et al. · Neurochemical Research · 2021
  26. Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl‐3‐(1‐propionylpiperidin‐4‐yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome‐related pro‐inflammatory and anti‐inflammatory signaling pathways in the lipopolysaccharide‐induced pain mouse model TR Ali Cagli et al. · Drug Development Research · 2021 · cites 2 articles of this academic
  27. mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats TR Demet Sinem Guden et al. · Canadian Journal of Physiology and Pharmacology · 2021 · cites 7 articles of this academic
  28. DOI 10.1017/erm.2021.16 2021
  29. DOI 10.1007/s10787-020-00782-8 2021
  30. DOI 10.3390/ijms22189775 2021 · cites 2 articles of this academic

Showing the 30 most recent.

Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Field ranking

Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.

YÖKSİS ?

Works 30

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 3 articles
OpenAlex citation percentile
Top 1%1
Top 10%3
Avg · n 25 %64.6
Other counts

Scopus (SJR)

  • YÖKSİS rows 22

WoS (JCR)

  • YÖKSİS rows 25

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

30articles

Journals with publications

17 journals

Narrow down

Scopus (SJR)
Q10 Q216 Q33 Q43
WoS (JCR)
Q11 Q23 Q313 Q48
TR Index
3articles

Article list

  1. 2024 mTORC2 inhibition by JR-AB2-011 improves IL-1β-induced inflammation, catabolic response, and apoptosis in human chondrocytes through IκB-α/NF-κB p65 Cellular and Molecular Biology DOI 10.14715/cmb/2024.70.9.5 YÖKSİS SJR Q4 JCR Q4 OpenAlex 56.9%
  2. 2024 Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/ NF-κB activation PROSTAGLANDINS & OTHER LIPID MEDIATORS DOI 10.1016/j.prostaglandins.2024.106918 YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
  3. 2023 NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IkB-a/NF-kB signaling pathway activity Cellular and Molecular Biology DOI https://pubmed.ncbi.nlm.nih.gov/37807339/ YÖKSİS SJR Q4 JCR Q4 OpenAlex 78.0%
  4. 2023 Pro-inflammatory GPR75 and anti-apoptotic phospholipase signaling pathways contribute to the ameliorating effect of soluble epoxide hydrolase inhibition on chronic experimental autoimmune encephalomyelitis in mice. Cell Mol Biol DOI 10.14715/cmb/2023.69.10.2. YÖKSİS SJR Q4 JCR Q4 OpenAlex 66.5%
  5. 2023 Pyroptosis and necroptosis inhibitor necrosulfonamide ameliorates lipopolysaccharide-induced inflammatory hyperalgesia in mice Pharmacia DOI 10.3897/pharmacia.70.e108995 YÖKSİS JCR Q4 OpenAlex 65.4%
  6. 2023 mTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury Cukurova Medical Journal DOI 10.17826/cumj.1353689 YÖKSİS TR Index JCR Q3 OpenAlex 53.3%
  7. 2022 Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock Journal of Cardiovascular Pharmacology DOI 10.1097/FJC.0000000000001265 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 99.3%
  8. 2022 Pharmacological inhibition of mTOR attenuates DOCA-salt-induced hypertension and related pathophysiology: regulation of oxidative stress, inflammation and cardiovascular hypertrophy in male rats. Journal of Cardiovascular Pharmacology DOI 10.1097/fjc.0000000000001187 YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.4%
  9. 2022 Bexarotene Ameliorates LPS-Induced Hyperalgesia: Contribution of TLR4/MyD88-Dependent Pro-Inflammatory, Anti-Apoptotic and Anti-Inflammatory Signaling Pathways International Journal of Pharmacology DOI 10.3923/ijp.2022.1171.1188 YÖKSİS SJR Q3 JCR Q4 OpenAlex 62.7%
  10. 2022 Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MERK1/ERK1/2 activity. Cukurova Medical Journal DOI 10.17826/cumj.1021518 YÖKSİS TR Index JCR Q3 OpenAlex 2.9%
  11. 2021 mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY YÖKSİS SJR Q2 JCR Q4 OpenAlex 54.8%
  12. 2021 Involvement of Rho-kinase/IκB-α/NF-κB activation in IL-1β-induced inflammatory response and oxidative stress in human chondrocytes Canadian Journal of Physiology and Pharmacology DOI 10.1139/cjpp-2020-0305 YÖKSİS SJR Q2 JCR Q4 OpenAlex 79.1%
  13. 2021 Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model DRUG DEVELOPMENT RESEARCH YÖKSİS SJR Q3 JCR Q2 OpenAlex 61.1%
  14. 2021 Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model Neurochemical Research DOI http://link.springer.com/10.1007/s11064-020-03197-7 YÖKSİS SJR Q2 JCR Q2
  15. 2020 Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner INFLAMMOPHARMACOLOGY DOI http://link.springer.com/10.1007/s10787-020-00691-w YÖKSİS SJR Q2 JCR Q1
  16. 2019 Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock PROSTAGLANDINS OTHER LIPID MEDIATORS DOI 10.1016/j.prostaglandins.2019.106377 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.0%
  17. 2019 Modulation of oxidative–nitrosative stress and inflammatory response by rapamycin in target and distant organs in rats exposed to hindlimb ischemia–reperfusion: the role of mammalian target of rapamycin CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY DOI 10.1139/cjpp-2019-0394 YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.2%
  18. 2019 NF-κB activation mediates LPS- or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY DOI 10.1111/1440-1681.13045 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.7%
  19. 2019 Targeting mTOR: up-to-date mTOR inhibitors Bioorganic Medicinal Chemistry Reports YÖKSİS OpenAlex 11.7%
  20. 2019 Yaşa bağlı gelişen bozukluklarda polifenoller ve hedefleri mTOR sinyal ileti yolu Mersin Üniversitesi Sağlık Bilimleri Dergisi YÖKSİS TR Index OpenAlex 19.9%

Projects 11 See all (11) →

  1. 2023 İnsan kondrosit hücrelerinde IL-1β ile indüklenmiş inflamatuvar, katabolik ve apopitotik süreçlerde mTORK2’nin rolü Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2023-07-31 – 2024-07-31
  2. 2017 İnsan kondrositlerinde IL-1β ile indüklenmiş inflamasyonda Rho-Kinaz'ın rolünün araştırılması: IkB-α/NF-kB yolağına katkısı Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2017-07-03 – 2021-08-13
  3. 2021 Farelerde oluşturulan kronik deneysel otoimmün ensefalomiyelit modelinde çözünebilir epoksit hidrolaz inhibisyonunun GPR75/FLC/PI3K/Akt1'e bağımlı antiapopitotik sinyal ileti yolu üzerindeki etkisinin araştırılması. -Tübitak 1002 · Tamamlandı 2021-10-01 – 2022-04-01
  4. 2020 Farelerde olusturulan enflamatuvar hiperaljezi modelinde dokozahekzaenoik asidin Traf6/Ikk/Nf-Kb yolu üzerindeki etkisinin antienflamatuvar Nlrx1 ile iliskilendirilerek araştırılması -Tübitak 1002 · Tamamlandı 2020-04-01 – 2021-11-26
  5. 2018 Sıçanlarda DOCA-tuz modeli ile oluşturulan deneysel hipertansiyon ve ilişkili kardiyovasküler ve renal patofizyolojik değişikliklerde mTOR’un katkısının araştırılması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2018-01-02 – 2022-05-26

Books 1

  1. 2025 Farmakolojide Güncel Çalışmalar II Livre de Lyon ISBN 978-2-38236-080-4 Kitap Bölümü · Bilimsel Kitap

Proceedings 49 See all (49) →

  1. 2018 Protective effect of mTOR inhibition on lps-induced systemic inflammation and tissue injury: contribution of mTOR/IκB-α/NF-κB/HIF-1α signaling pathway and NADPH oxidase system activity 12th International Symposium on Pharmaceutical Science
  2. 2019 Rapamycin reverses kidney injury in DOCA-salt induced hypertensive rats: Contribution of mTOR. 2nd International Eurasian Conferences on Biological and Chemical Sciences
  3. 2014 Sağlığın Sembolü Gılgamış Destanı ndan Asklepios a Yılan 11. Türk Eczacılık Tarihi Toplantısı
  4. 2020 Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? International Eurasian Conference on Biotechnology and Biochemistry
  5. 2020 mTOR Contributes to Cardiovascular Injury Caused by DOCA-Salt Administration in Rats 5th International Hippocrates Congress on Medical and Health Sciences

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
41
With an akaturk profile
13
Turkish institutions
3
Co-authored works
%100

Academic co-authors 13

  1. SEYHAN ŞAHAN FIRAT Profesör · Mersin Üniversitesi same university 29
  2. BAHAR TUNÇTAN Profesör · Mersin Üniversitesi same university 25
  3. ŞEFİKA PINAR ŞENOL Doktor Öğretim Üyesi · Tarsus Üniversitesi 20
  4. CÜNEYT KEMAL BUHARALIOĞLU Profesör · İzmir Katip Çelebi Üniversitesi 3
  5. LÜLÜFER TAMER Profesör · Mersin Üniversitesi same university 3
  6. ŞAKİR NECAT YILMAZ Profesör · Mersin Üniversitesi same university 3
  7. DENİZ KİBAR Araştırma Görevlisi · Mersin Üniversitesi same university 2
  8. RUKİYE NALAN TİFTİK Doçent · Mersin Üniversitesi same university 2
  9. AYÇA AKTAŞ ŞÜKÜROĞLU Doçent · Mersin Üniversitesi same university 1
  10. GÜLSEN BAYRAK Doktor Öğretim Üyesi · Uşak Üniversitesi 1
Show all (13)
  1. HATİCE YILDIRIM YAROĞLU Doçent · Mersin Üniversitesi same university 1
  2. İSMAİL ÜN Profesör · Mersin Üniversitesi same university 1
  3. ŞENAY BALCI FİDANCI Doçent · Mersin Üniversitesi same university 1

National collaboration 3 institutions

Within own university30 joint works · Mersin Üniversitesi

  1. Tarsus Üniversitesi 20 works · 1 academics
  2. İzmir Katip Çelebi Üniversitesi 3 works · 1 academics
  3. Uşak Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 28

DEMET SİNEM GÜDEN YILDIRIM 21KAFAIT ULLAH MALIK 15AYŞE NİHAL SARI 11JOHN RICHARD FALCK 4MEHMET FURKAN HORAT 4NEHİR SUCU 4ÖMER BAHÇELİ 4ÖZDEN VEZİR 4DEMET ÜNSAL 3Dilşah Ezgi Yılmaz 3Banu Kılıç 2Belma Korkmaz 2MELTEM KAÇAN 2MUSTAFA SERHAN SEVİM 2Pelin Çeçen 2Taşkın KALKAN 2ZAINAB SABRIE 2ZÜMRÜT KOÇAK 2AYŞEGÜL GÖRÜRAbdurrahman DolunayAli CağliBEYZA ÖZGENMAHESH PAUDYALMerve BiliktuRaghunath Reddy AnuguRambabu DAKARAPUZARİFE PİREÇağla Akıncı Uysal

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.